604 results
Initial Anticoagulation for Venous Thromboembolism (VTE)

#Anticoagulation #Initial #Initiation #Dosing #Venous #Thromboembolism #VTE #Pharmacology #Table #Management
Anticoagulation for Venous ... Thromboembolism ... (VTE) #Anticoagulation ... #Thromboembolism ... #VTE #Pharmacology
Venous Thromboembolism Treatment Algorithm
Branch points: 
Active bleeding?  Active malignancy? Provoked?

- Dr. Joseph Shatzel
@Clotmaster

#Management #VTE #DVT
Venous Thromboembolism ... #Management #VTE ... DVT #Algorithm #Venous ... #Thromboembolism
Venous Thromboembolism (VTE) in IBD - IBD Algorithm

 • 2-3x risk VTE vs non-IBD
 • VTE/AT
Venous Thromboembolism ... (VTE) in IBD - ... • 2-3x risk VTE ... @wabillin #Venous ... #Thromboembolism
Algorithm for the Long-Term Treatment of Venous Thromboembolism 

Reference: https://doi.org/10.1182/blood.2019002364

by Dr. Clive Kearon and Dr. Susan
Long-Term Treatment of Venous ... Thromboembolism ... LongTerm #Treatment #Venous ... #Thromboembolism ... #VTE #Anticoagulation
Checklist for for Managing Confirmed VTE in Pregnancy

Pre-Delivery, Peri-Delivery and Post-Delivery Checklists

#Management #Obstetrics #OBGyn #Checklist #VTE
Managing Confirmed VTE ... OBGyn #Checklist #VTE ... #Venous #Thromboembolism
Venous Thromboembolism Prophylaxis - Pharmacology Comparison Table

UFH vs Enoxaparin vs Fondaparinux

#VTE #DVT #Prophylaxis #Pharmacology #Comparison #Table
Venous Thromboembolism ... Fondaparinux #VTE
Approach to the Hypercoagulable State
Arterial thromboembolism
→ Cardiac rhythm monitoring, Echocardiogram, Vascular imaging
→ Test for APS, particularly
history of prior venous ... (VTE). ... arterial thrombosis) Venous ... - Recurrent VTE ... algorithm #hematology #VTE
Duration of Treatment of Venous Thromboembolism (VTE)
 - Major transient risk factor (eg, major surgery, major
of Treatment of Venous ... Thromboembolism ... (VTE) - Major ... Indefinite #VTE ... #Thromboembolism
Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

https://www.nejm.org/doi/full/10.1056/NEJMoa1711948

Authors’ Conclusions: “Oral edoxaban was noninferior to subcutaneous dalteparin
Cancer-Associated Venous ... Thromboembolism ... thromboembolism ... respect to recurrent VTE ... VenousThromboembolism #VTE
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
body mass index; VTE ... = venous thromboembolism ... #DOAC #VTE #Malignancy